In oncology, we increasingly notice an introduction of novel oral treatments. While this is certainly more convenient for patients and the benefits of this are great, patients’ non-adherence is now becoming a new challenge in oncology.

Over recent years, Ingress-Health has gained extensive knowledge in this particular topic. Please find below our recording of the webinar (held 23rd June 2020) where we share our experience, thoughts and the recent developments in this field of research.